Abstract:OBJECTIVE To study the pharmacokinetics and relative bioavailability of the sustained-release alfuzosin hydrochloride capsules in healthy Beagle dogs.METHODS Following a single oral dose of the sustained-release alfuzosin hydrochloride capsules(test formulation) and conventional tablets(reference formulation) to each of the 6 healthy beagle dogs in a randomized crossover design,the plasma levels of the active drugs at different-time points were determined by HPLC and the plasma concentration-time curves of these formulations were obtained.The pharmacokinetic parameters as well as the relative bioavailability were analyzed.RESULTS The t2max values of the test formulation and reference formulation were(1.42±0.49) and(0.79±0.19) h.The ρ2max values were(323.92±70.82) and(508.31±120.62) μg·L2-1,and the AUC20-t were(1 082.99±290.75) and(1 174.56±336.31) μg·h·L2-1,respectively.The relative bioavailability of the test formulation was found to be(92.20±14.94)% compared with the reference formulation.The variance analysis showed no significant difference between the test and reference formulation in periods and formulations(P0.05),but significant difference was obtained in subjects.The 90% confidence interval of AUC20-t of the test formulation was 82.5%~108.2 %,compared with the reference formulation.CONCLUSION Compared with the alfuzosin hydrochloride conventional tablets,the sustained-release alfuzosin hydrochloride capsules have longer action time in dogs and similar relative bioavailability.

Pharmacokinetics of Melatonin Sustained Release Tablets and Common Tablets in Beagle Dogs

Study on Pharmacokinetics of Melatonin Orally Disintegrating Tablets and Common Tablets in Beagle Dogs

Study on Preparation of Levetiracetam Sodium Extended-release Tablet and It's Pharmacokinetics in Beagle Dogs

Pharmacokinetics and Bioavailability of Meloxicam Tablet in beagle dogs

A Comparison Study of Main Pharmacokinetic Parameters on Pridinol Mesylate Orally Disintegrating Tablets and Conventional Tablets in Beagle Dogs

Bioequivalence and pharmacokinetics characteristics of clozapine sustained release tablets in Beagle dogs

Pharmacokinetics and Relative Bioavailability of Sustained-Release Alfzosin Hydrochloride Capsules in Healthy Beagle Dogs

Pharmacokinetics of Extended-release Tablets of Quetiapine in Beagle Dogs by HPLC-MS/MS Method

A Pharmacokinetic Study on Carteolol Hydrochloride Matrix Sustained-release Pellets in Beagle Dogs

Bioequivalence and Pharmacokinetic Characteristics of Lovastatin Sustained Release Tablets in Beagle Dogs

Pharmacokinetics of Oxymatrine Bioadhesive Sustained-Release Tablets in Beagle Dogs

The study of pharmacokinetics of metoprolol succinate sustained release tablets in dogs

Preparation of Marine Gastro-Retentive Sustained-Release Tablets and Evaluation of Its Bioavailability in Beagle Dogs

Pharmacokinetics of cetirizine/pseudoephedrine sustained release tablets in Beagle dogs

Pharmacokinetics and bioequivalence of nicotinic acid sustained-release capsules in beagle dogs

Metabolism and Relative Bioavailability of Oxymatrine Sustained-Release Tablets in Beagle Dogs

Study on pharmacokinetics of sustain-realease tablets of niacin and lovastatin in Beagle dogs

Pharmacokinetics of Propafenone Hydrochloride Sustained-Release Capsules in Male Beagle Dogs

Pharmacokinetics of carvedilol floating tablets in Beagle dogs

In Vitro Release and Pharmacokinetics of Sustained-release Tablets Loaded with Felodipine in Beagle Dogs

Study on the Bioavailability and Pharmacokinetics of Guaiphenesin Sustained Release Tablets in Beagle Dogs